1-year probability of default median for public U.S. healthcare industries 2020-2021
In 2020, public pharmaceutical companies in the United States had a 7.7 percent probability of default at its peak. However, the probability decreased to 1.6 percent as of March 2021. This statistic illustrates the 1-year probability of default median for public U.S. healthcare companies comparing the 2020-high to March 2021, by primary industry.